Skip to main content
get in touch

Research Report · Feb 16, 2026

Preventable Hospital Readmissions

Date: February 16, 2026 Problem: Patients discharged without adequate follow-up cause ~$26B/yr in preventable 30-day readmissions; hospitals face CMS penalties under the Hospital Readmissions Reduction Program (HRRP).

Note: This report draws on published data from CMS, AHRQ, KFF, AHA, peer-reviewed literature, and market research firms (Grand View Research, MarketsandMarkets, Fortune Business Insights) available through early 2025. Where live web retrieval was unavailable, figures reflect the most recent widely-cited data. Sources with URLs are listed in Section 9.

Author: Rigid Body Dynamics

1. PROBLEM MARKET SIZE

Total Cost of Preventable Readmissions in the US

MetricValueSource / Year
Total cost of all 30-day hospital readmissions (Medicare)~$26B per yearCMS / AHRQ, 2023 estimate
Estimated share deemed preventable50-75% (method-dependent)Jencks et al. (NEJM); AHRQ
Preventable readmission cost (conservative 50%)~13B13B-17B per yearDerived
Total cost including all payers (Medicare + Medicaid + commercial)~41B41B-52B per yearVarious; AHA estimates
  • The oft-cited "$26 billion" figure originates from Medicare-only data. When Medicaid and commercial payers are included, the aggregate cost is substantially higher.
  • CMS estimates that roughly 2 million Medicare beneficiaries are readmitted within 30 days annually, at an average cost of ~13,00013,000-15,000 per readmission episode.

CMS HRRP Penalties

MetricValueSource / Year
Total HRRP penalties (FY 2024)~$521 millionCMS Final Rule FY 2024
Total HRRP penalties (FY 2023)~$521 millionCMS Final Rule FY 2023
Cumulative penalties since program inception (FY 2013-2024)~$6.5 billionKFF / Advisory Board analysis
Maximum penalty per hospital3% of base DRG paymentsCMS statute
Average penalty among penalized hospitals~0.64% of base payments (FY 2024)CMS data

2. CURRENT SPEND TO MANAGE

Care Management Software Market

MetricValueSource
Market size (2023)~$14.4 billionGrand View Research
Market size (2024, estimated)~$16.1 billionGrand View Research
Projected size (2030)~3232-36 billionGrand View Research / MarketsandMarkets
CAGR (2024-2030)12.1-13.5%Grand View Research

Transitional Care / Transition of Care Services Market

MetricValueSource
Market size (2023)~$6.8 billion (US)MarketsandMarkets
Projected size (2030)~$14.2 billionMarketsandMarkets
CAGR (2024-2030)~11.0%MarketsandMarkets

Population Health Management (PHM) Market

MetricValueSource
Global market size (2023)~$31.5 billionFortune Business Insights
Global market size (2024, estimated)~$36.5 billionFortune Business Insights
Projected size (2030)~8181-89 billionFortune Business Insights / Grand View Research
CAGR (2024-2030)14.5-16.2%Fortune Business Insights
US share of global PHM market~45-50%Industry estimates

Remote Patient Monitoring (RPM) Market (Adjacent)

MetricValueSource
Market size (2023)~$5.9 billion (US)Grand View Research
Projected size (2030)~$15.6 billionGrand View Research
CAGR~14.9%Grand View Research

3. COST OF INACTION

Average Cost of a Single Readmission

ConditionAvg. Cost per ReadmissionSource
All-cause (Medicare)13,80013,800 - 15,200AHRQ HCUP, 2023
Heart failure (CHF)14,60014,600 - 16,500AHRQ
COPD12,80012,800 - 13,900AHRQ
Pneumonia13,10013,100 - 14,700AHRQ
Hip/Knee replacement14,20014,200 - 16,800AHRQ
AMI (Acute Myocardial Infarction)15,50015,500 - 17,200AHRQ
CABG (Coronary Artery Bypass Graft)17,00017,000 - 21,000AHRQ

CMS Penalty Impact per Hospital

MetricValue
Maximum HRRP penalty3% of total base DRG payments
For a mid-size hospital (~$200M Medicare revenue)Up to $6 million/year
For a large academic medical center (~$800M Medicare rev.)Up to $24 million/year
Average penalty among penalized hospitals (FY 2024)~200,000200,000 - 350,000
Median penalty (FY 2024)~$140,000

Percentage of Readmissions Deemed Preventable

  • Conservative estimates: 27-30% of all 30-day readmissions are preventable (Auerbach et al., BMJ Quality & Safety, 2016; reaffirmed in 2023 meta-analyses).
  • Broader estimates: Up to 75% may be avoidable with optimal discharge planning, medication reconciliation, and follow-up (Jencks et al., NEJM 2009; updated AHRQ analyses).
  • CMS working estimate: ~50% of readmissions have a modifiable component.
  • Most-cited range in policy discussions: 40-60% preventable.

Impact on Hospital Margins

MetricValueContext
Average US hospital operating margin (2023)2.7% (median)Kaufman Hall
Average US hospital operating margin (2024)3.2% (median)Kaufman Hall
HRRP penalty as % of operating marginCan represent 10-40% of operating profit for penalized hospitalsDerived
Readmission cost absorbed by hospital (under bundled/VBC contracts)100% of incremental costCMS BPCI data
Estimated margin erosion from excess readmissions (safety-net hospital)1.5-3.0 percentage pointsAHA analysis

Safety-net hospitals and rural hospitals are disproportionately affected. A 2024 AHA analysis showed that hospitals with higher shares of dual-eligible patients face systematically higher HRRP penalties, contributing to a two-tier penalty system that critics call inequitable.


4. VOLUME AND FREQUENCY

Total 30-Day Readmissions

MetricValueSource / Year
Total Medicare 30-day readmissions per year~1.9 - 2.1 millionCMS, 2023-2024
All-payer 30-day readmissions (estimated)~3.5 - 3.8 millionAHRQ HCUP extrapolation
Overall 30-day readmission rate (Medicare FFS)~15.0-15.5%CMS 2023 data (down from 19.5% in 2010)

Readmission Rates by Condition (Medicare, 2023-2024)

Condition30-Day Readmission RateTrend
Heart Failure (CHF)20.0-21.5%Declining (was 24.8% in 2010)
COPD18.5-19.8%Declining (was 21.1% in 2010)
Pneumonia15.5-16.8%Declining (was 18.5% in 2010)
AMI15.0-16.2%Declining (was 19.9% in 2010)
Hip/Knee Replacement4.5-5.2%Declining (was 5.8% in 2010)
CABG11.5-12.8%Declining

Hospitals Penalized Under HRRP

Fiscal YearHospitals Penalized% of Eligible HospitalsSource
FY 2023~2,273~77%CMS
FY 2024~2,180~76%CMS
FY 2025 (projected)~2,100-2,200~74-76%CMS / Advisory Board
Total eligible hospitals evaluated~2,800-2,900--CMS

Key insight: Roughly three-quarters of all evaluated hospitals receive some level of HRRP penalty each year, making this one of the most broadly applied CMS quality penalties.


5. WHY STILL UNSOLVED

Post-Discharge Contact Gaps

  • 48-hour follow-up failure: Only 50-55% of discharged patients receive a follow-up call within 48 hours. Evidence shows that structured post-discharge calls within 48-72 hours reduce readmissions by 20-30%.
  • 7-day physician follow-up: Only ~40-45% of Medicare patients see their PCP within 7 days of discharge (CMS data, 2023). For CHF patients, this drops to ~38%.
  • Medication reconciliation gaps: 50-70% of patients experience at least one medication discrepancy at discharge. Adverse drug events account for ~20% of preventable readmissions.
  • Patient comprehension: Studies show 40-80% of medical information provided at discharge is forgotten immediately. Only 12% of adults have proficient health literacy (AHRQ).

Social Determinants of Health (SDOH)

  • Food insecurity: Patients with food insecurity have 1.5x higher readmission rates.
  • Housing instability: Homeless or housing-insecure patients have 2-3x higher readmission rates.
  • Transportation barriers: ~3.6 million Americans miss or delay medical care annually due to transportation issues (AHRQ). This directly affects post-discharge follow-up attendance.
  • Social isolation: Patients living alone have 25-30% higher readmission risk, particularly for CHF.
  • Dual-eligible patients: Medicare-Medicaid dual-eligible beneficiaries have readmission rates 1.4-1.8x higher than Medicare-only patients.
  • Behavioral health comorbidities: Depression increases 30-day readmission risk by 40-50%.

Care Transition Handoff Failures

  • Discharge summary delays: Only 12-34% of discharge summaries are available at the time of the first follow-up visit (Kripalani et al., JAMA Internal Medicine).
  • PCP notification gaps: ~25% of PCPs report not being notified when their patients are hospitalized.
  • Fragmented EHR systems: Despite widespread EHR adoption, interoperability remains poor. Only ~30-40% of hospitals can electronically exchange patient summaries with community providers in real time.
  • Handoff protocol non-adherence: Even when structured handoff tools exist (e.g., IDEAL, RED, Project BOOST), adherence rates range from 40-65% due to time pressure and staffing shortages.

Systemic / Structural Barriers

  • Nursing shortages: Post-pandemic nursing shortages have reduced discharge planning capacity. The average hospital care manager caseload increased from 15-20 patients to 25-35 patients (2020-2024).
  • Fee-for-service incentive misalignment: Under FFS, readmissions generate revenue. Despite HRRP penalties, many hospitals still net positive on readmissions if the penalty is < marginal revenue from the readmit. The transition to value-based care is incomplete (~40% of Medicare payments are VBC as of 2024).
  • Short hospital stays / early discharge pressure: Average length of stay has declined from 5.4 days (2010) to 4.6 days (2023), increasing post-discharge vulnerability.
  • Limited home health capacity: Home health agencies face their own workforce shortages, leading to delayed or unavailable post-discharge home visits.

6. WILLINGNESS TO PAY SIGNALS

What Hospitals / ACOs / Payers Currently Pay

Solution CategoryTypical Annual Spend per Hospital / OrganizationNotes
Care management / coordination platforms200K200K - 1.5M/yearPer hospital; varies by bed count
Remote patient monitoring (RPM) programs150K150K - 800K/yearPer program; per-patient cost ~100100-175/month
Transitional care nurse programs300K300K - 600K/year2-4 dedicated transitional care nurses
Discharge planning software (standalone)50K50K - 250K/yearSaaS licensing
Population health analytics platforms500K500K - 3M/yearEnterprise licenses for large health systems
Post-discharge call center services (outsourced)100K100K - 400K/yearPer facility
SDOH screening and referral platforms30K30K - 150K/yearEmerging category (e.g., Unite Us, findhelp)
Bundled payment / episode management tools200K200K - 1M/yearFor BPCI-A participants

Evidence of Strong Willingness to Pay

  1. CMS Bundled Payments (BPCI-A): Over 1,200 hospitals and physician groups participate in BPCI Advanced, taking on financial risk for 90-day episode costs including readmissions. This demonstrates willingness to invest in readmission prevention to retain shared savings.

  2. ACO spending on care management: Medicare Shared Savings Program (MSSP) ACOs collectively spent an estimated 2.52.5-3.5 billion on care management infrastructure in 2023-2024.

  3. Health system capital allocation: Large health systems (e.g., CommonSpirit, HCA, Ascension) have allocated 50M50M-200M+ in multi-year investments for population health and care management platforms.

  4. Payer investments: United Healthcare, Humana, Aetna, and other major payers have built or acquired care management capabilities costing hundreds of millions annually (e.g., Optum's $13B acquisition of Change Healthcare included care coordination tools; Humana's CenterWell home health investment).

  5. ROI evidence driving spend: Multiple studies show 22-6 return per $1 invested in structured transitional care programs (Naylor et al., Transitional Care Model; Coleman Care Transitions Intervention). This strong ROI evidence supports continued and growing investment.

  6. CMS penalty avoidance math: A hospital facing 15MinannualHRRPpenaltieshasclearfinancialjustificationtospend1-5M in annual HRRP penalties has clear financial justification to spend 500K-$2M on readmission reduction programs.


7. MARKET GROWTH RATE

Market SegmentCAGR (2024-2030)Source
Population Health Management14.5-16.2%Fortune Business Insights / Grand View Research
Care Management Software12.1-13.5%Grand View Research / MarketsandMarkets
Remote Patient Monitoring14.9-17.8%Grand View Research
Transitional Care Services~11.0%MarketsandMarkets
Clinical Decision Support~10.5%Fortune Business Insights
Healthcare AI (broad, relevant subset)38-45%Grand View Research / Precedence Research
SDOH Data & Analytics~20-25%Estimated from multiple sources

Growth Drivers:

  • Expansion of CMS value-based care models (ACO REACH, MSSP, BPCI-A)
  • HRRP penalty expansion to include additional conditions
  • CMS interoperability mandates (TEFCA, information blocking rules)
  • AI/ML adoption for predictive readmission risk scoring
  • Post-pandemic shift toward hospital-at-home and virtual care
  • Medicaid expansion of readmission penalties in multiple states

8. KEY PLAYERS TODAY

Major Care Management / Population Health Platforms

CompanyEst. Revenue (2023-2024)Focus AreaNotes
Evolent Health (EVH)~1.81.8-2.0B (2024 revenue)Value-based care enablement, specialty care managementPublicly traded; acquired NIA Magellan specialty assets. Strong growth trajectory.
Lightbeam Health Solutions~3030-50M (estimated)Population health analytics, care gap closurePrivate; serves ~400+ provider organizations. Acquired by Inovalon (2021), which was taken private by Nordic Capital.
MedalliaAcquired by Thoma Bravo for $6.4B (2021)Patient experience, not core care managementPrimarily CX platform; healthcare vertical is a subset. Less directly relevant to readmission prevention.
Caradigm (now part of GE HealthCare / legacy)Largely sunsetWas a Microsoft-GE joint venture for PHMDissolved/absorbed; no longer a standalone player.

Other Significant Players in This Space

CompanyEst. Revenue (2023-2024)Focus Area
Optum / UnitedHealth Group>$20B (Optum Health segment)End-to-end care management, analytics, population health
Epic Systems (Healthy Planet module)~$4.6B total (2023)Embedded PHM within EHR; dominant in large health systems
Cerner / Oracle Health~$6B+ (Oracle Health Cloud)EHR + population health; Oracle investment in AI
Health Catalyst (HCAT)~310310-320M (2024)Data analytics, outcomes improvement, care management
Innovaccer~150150-200M (estimated)Health data platform, care management, PHM
CarePort Health (WellSky)Part of WellSky (~$600M total)Post-acute care coordination, discharge planning
Bamboo Health~100100-150M (estimated)Care coordination, real-time patient alerts, PDMP
PointClickCare~500500-700M (estimated)Post-acute / long-term care EHR and care coordination
Enhabit Home Health & Hospice~$1.1B (2023)Home health services for post-discharge care
Amedisys (merging with UHS/Optum)~$1.9B (2023)Home health; acquired by UnitedHealth/Optum
Unite Us~7070-100M (estimated)SDOH referral network
Current Health (Best Buy Health)Part of Best Buy HealthHospital-at-home, RPM for transitional care
Biofourmis~5050-80M (estimated)AI-driven RPM, hospital-at-home

Competitive Landscape Summary

The market is fragmented. No single vendor provides a complete readmission-prevention solution spanning predictive analytics + care coordination + post-discharge engagement + SDOH integration + RPM. This creates opportunity for:

  • Integrated platforms that unify these capabilities
  • AI-first solutions that can predict and intervene more effectively than rule-based systems
  • Solutions targeting the specific gap between hospital discharge and primary care re-engagement (the "danger zone" of 3-14 days post-discharge)

9. KEY SOURCES

Government and Regulatory Sources

  1. CMS Hospital Readmissions Reduction Program (HRRP) -- https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/hospital-readmissions-reduction-program-hrrp
  2. CMS FY 2024 IPPS Final Rule (readmission penalty data) -- https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps
  3. AHRQ Healthcare Cost and Utilization Project (HCUP) -- Readmission statistics and costs -- https://hcup-us.ahrq.gov/reports/statbriefs/sb248-Hospital-Readmissions-2010-2016.jsp
  4. AHRQ Health Literacy data -- https://www.ahrq.gov/health-literacy/index.html
  5. CMS BPCI Advanced Model -- https://innovation.cms.gov/innovation-models/bpci-advanced

Research and Policy Organizations

  1. Kaiser Family Foundation (KFF) -- HRRP Analysis -- https://www.kff.org/medicare/issue-brief/aiming-for-fewer-hospital-u-turns-the-medicare-hospital-readmission-reduction-program/
  2. Jencks SF, Williams MV, Coleman EA. "Rehospitalizations among Patients in the Medicare Fee-for-Service Program." NEJM 2009;360:1418-28 -- https://www.nejm.org/doi/full/10.1056/NEJMsa0803563
  3. Kripalani S et al. "Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians." JAMA Internal Medicine -- https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/410956
  4. Naylor MD et al. Transitional Care Model -- https://www.nursing.upenn.edu/ncth/transitional-care-model/
  5. Coleman EA. Care Transitions Intervention -- https://caretransitions.org/

Industry Analysis and Market Research

  1. Advisory Board / Optum Advisory -- Hospital Penalty Analysis FY 2024 -- https://www.advisory.com/daily-briefing/2023/10/04/hospital-readmission-penalties
  2. Kaufman Hall -- National Hospital Flash Report (operating margins) -- https://www.kaufmanhall.com/insights/research-report/national-hospital-flash-report
  3. American Hospital Association (AHA) -- Hospital statistics and HRRP equity concerns -- https://www.aha.org/
  4. Grand View Research -- Care Management Solutions Market -- https://www.grandviewresearch.com/industry-analysis/care-management-solutions-market
  5. Grand View Research -- Population Health Management Market -- https://www.grandviewresearch.com/industry-analysis/population-health-management-market
  6. MarketsandMarkets -- Transitional Care Management Market -- https://www.marketsandmarkets.com/
  7. Fortune Business Insights -- Population Health Management Market -- https://www.fortunebusinessinsights.com/population-health-management-market-103037

Company / Financial Sources

  1. Evolent Health -- SEC filings, investor presentations -- https://ir.evolenthealth.com/
  2. Health Catalyst -- SEC filings -- https://ir.healthcatalyst.com/
  3. Innovaccer -- Company information -- https://innovaccer.com/
  4. WellSky / CarePort -- https://wellsky.com/
  5. PointClickCare -- https://pointclickcare.com/

Additional Research

  1. Auerbach AD et al. "Preventability and Causes of Readmissions in a National Cohort of General Medicine Patients." JAMA Internal Medicine 2016 -- https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2498846
  2. Figueroa JF et al. "Characteristics and Outcomes of US Hospitals Penalized Under the HRRP." BMJ 2023 -- https://www.bmj.com/
  3. CMS Medicare Shared Savings Program -- ACO data -- https://www.cms.gov/medicare/payment/fee-for-service-providers/shared-savings-program

EXECUTIVE SUMMARY

Preventable hospital readmissions represent a **26B+annualproblemforMedicarealone,withallpayerestimatesreaching26B+ annual problem** for Medicare alone, with all-payer estimates reaching 41-52B. The CMS HRRP program penalizes ~76% of evaluated hospitals, extracting ~521Minannualpenalties,withcumulativepenaltiesexceeding521M in annual penalties, with cumulative penalties exceeding 6.5B since inception. Despite these financial pressures and a decade of focused attention, 30-day readmission rates remain stubbornly high at ~15% overall and >20% for heart failure.

The root causes are multi-factorial: post-discharge follow-up gaps (only ~50% of patients get a 48-hour call), medication reconciliation failures (50-70% have discrepancies), SDOH barriers (transportation, food, housing), fragmented health IT interoperability, and workforce shortages in care management. The transition from fee-for-service to value-based care remains incomplete (~40% of Medicare payments).

The addressable software/services market is large and fast-growing: care management software (16B,121316B, 12-13% CAGR), population health management (36B, 15-16% CAGR), and remote patient monitoring (6B,156B, 15% CAGR). Hospital willingness to pay is strong, driven by penalty avoidance (1-5M/year per hospital), VBC shared savings, and demonstrated 2-6x ROI on transitional care investments.

The market remains fragmented with no dominant integrated solution. The highest-value opportunity lies in AI-driven platforms that unify predictive risk scoring, automated post-discharge engagement, SDOH screening/referral, and real-time care coordination across the hospital-to-home transition gap.


Report compiled February 16, 2026. Data primarily from 2023-2025 sources. Revenue estimates for private companies are approximations based on available industry reporting and should be validated with primary research.